Skip to main content
HR 366 105th Congress House Health Alabama Artificial implants Blood Blood banks Breast cancer Breast implants Chemicals Civil Rights and Liberties, Minority Issues Class actions (Civil procedure) Commerce Defective products Discrimination in medical care Donation of organs, tissues, etc. Economics and Public Finance Environmental Protection Federal aid to health facilities Government Operations and Politics Government paperwork Hospital care

Breast Implant Accountability Act

Introduced: January 7, 1997 See on congress.gov
This bill died when the 105th Congress ended
It never became law before the 105th Congress (1997–1998) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 22, 1997
Referred to the Subcommittee on Health and Environment.
Jan 7, 1997
Referred to the House Committee on Commerce.
Jan 7, 1997
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Breast Implant Accountability Act - Requires each manufacturer of a breast implant to notify each individual with a silicone gel or saline implant implanted before 1994 that the manufacturer will pay for removal and will allow the recipient to select the physician and hospital or center for the removal.

Directs the Secretary of Health and Human Services to conduct or contract for research on the physiological, neurological, and immunological effects of chemicals found in, or used in the manufacture of, breast implants. Requires inclusion in the research of individuals who are included in a specified class action suit in Alabama, if they volunteer for the research.

Prohibits: (1) physicians from doing silicone breast implants without patient execution of a consent form prescribed by the Secretary and from refusing the treatment of a patient because the patient has received a breast implant; (2) grants to an organ procurement organization if the organization has allowed an individual who has a breast implant to donate an organ; and (3) licensing of any blood collection entity if the entity receives blood from such an individual.

What's happening now January 22, 1997

Referred to the Subcommittee on Health and Environment.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 366: Breast Implant Accountability Act. 105th Congress. Open America. https://openamerica.io/bill/105-HR-366/
MLA
"H.R. 366: Breast Implant Accountability Act." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-HR-366/.
Bluebook (legal)
H.R. 366, 105th Cong. (2026), https://openamerica.io/bill/105-HR-366/.
Markdown link
[H.R. 366: Breast Implant Accountability Act](https://openamerica.io/bill/105-HR-366/)
Report a problem